Formation of amyloid-β oligomers in brain vascular smooth muscle cells transiently exposed to iron-induced oxidative stress

Acta Neuropathologica

Volumn 117, Issue 5, 2009, Pages 557-567

  Frackowiak, Janusz ^a   Potempska, Anna ^a   Mazur Kolecka, Bozena ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

A oligomers; APP transgenic mouse; Cell culture; Oxidative stress; Vascular amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FERROUS ION; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BRAIN HEMORRHAGE; CELL CULTURE; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IRON BLOOD LEVEL; IRON TRANSPORT; MOUSE; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; VASCULAR SMOOTH MUSCLE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; IRON; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; TIME FACTORS;

EID: 64449085276     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0497-0     Document Type: Article

References (65)

1. Alemany M, Stenborg A, Terent A, Sonninen P, Raininko R (2006) Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data. Radiology 238:240-247. doi: 10.1148/radiol.2381040551
2. Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, Beyreuther K, Carrington D, Masters CL, Cherny RA, Cappai R, Bush AI (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. FASEB J 18:1427-1429
3. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414-423. doi: 10.1016/j.neurobiolaging.2006.02.005
4. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664. doi: 10.1016/S0197-4580(01)00340-2
5. Butterfield DA, Kanski J (2002) Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42. Peptides 23:1299-1309. doi: 10.1016/ S0196-9781(02)00066-9
6. Carter P (1970) Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 40:450-458. doi: 10.1016/0003-2697(71)90405-2
7. Catalano SM, Dodson EC, Henze DA, Joyce JG, Krafft GA, Kinney GG (2006) The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr Top Med Chem 6:597-608. doi: 10.2174/ 156802606776743066
8. Chen JW, Chen GL, D'Souza MP, Murphy TL, August JT (1986) Lysosomal membrane glycoproteins: Properties of LAMP-1 and LAMP-2. Biochem Soc Symp 61:97-112
9. Cole GM, Huynh TV, Saitoh T (1989) Evidence for lysosomal processing of amyloid β-protein precursor in cultured cells. Neurochem Res 4:933-939. doi: 10.1007/BF00965926
10. Coma M, Guix FX, Ill-Raga G, Uribesalgo I, Alameda F, Valverde MA, Muñoz FJ (2008) Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiol Aging 29:969-980. doi: 10.1016/j.neurobiolaging.2007.01.009
11. Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW (1997) Alzheimer's A beta (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 3:1021-1023. doi: 10.1038/nm0997-1021
12. Cullen K, Kócsi Z, Stone J (2006) Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 27:1786-1796. doi: 10.1016/ j.neurobiolaging.2005.10.016
13. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE (1995) Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 65:931-934
14. Deshpande A, Mina E, Glabe C, Busciglio J (2006) Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011-6018. doi: 10.1523/ JNEUROSCI.1189-06.2006
15. Ditaranto K, Tekirian TL, Yang AJ (2001) Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease. Neurobiol Dis 8:19-31. doi: 10.1006/nbdi.2000.0364
16. Frackowiak J, Zoltowska A, Wisniewski HM (1994) Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53:637-645. doi: 10.1097/00005072-199411000-00011
17. Frackowiak J, Mazur-Kolecka B, Wisniewski HM, Potempska A, Carroll RT, Emmerling MR, Kim KS (1995) Secretion and accumulation of β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 676:225-230. doi: 10.1016/0006-8993(94)01465-T
18. Frackowiak J, Miller DL, Potempska A, Sukontasup T, Mazur-Kolecka B (2003) Secretion and accumulation of Aβ by brain vascular smooth muscle cells from AβPP-Swedish transgenic mice. J Neuropathol Exp Neurol 62:685-696
19. Frackowiak J, Sukontasup T, Potempska A, Mazur-Kolecka B (2004) Lysosomal deposition of Aβ in cultures of brain vascular smooth muscle cells is enhanced by iron. Brain Res 1002:67-75. doi: 10.1016/ j.brainres.2003.12.015
20. Garzon-Rodriguez W, Yatsimirsky AK, Glabe CG (1999) Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence. Bioorg Med Chem Lett 9:2243-2248. doi: 10.1016/ S0960-894X(99)00357-1
21. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides. Proc Natl Acad Sci USA 96:742-747. doi: 10.1073/ pnas.96.2.742
22. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer's disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417-10422. doi: 10.1073/pnas.1834302100
23. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20
24. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer's disease A beta 40/42 amyloid peptides. Nat Med 3:1016-1020. doi: 10.1038/nm0997-1016
25. Hook VY, Reisine TD (2003) Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: Role of BACE 1 in the constitutive secretory pathway. J Neurosci Res 74:393-405. doi: 10.1002/ jnr.10784
26. Hsiao KK, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274:99-102. doi: 10.1126/ science.274.5284.99
27. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G (2006) Long-term effects of experimental intracerebral hemorrhage: The role of iron. J Neurosurg 104:305-312. doi: 10.3171/jns.2006.104.2.305
28. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609-7616. doi: 10.1021/ bi990438f
29. Klein WL (2002) Abeta toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41:345-352. doi: 10.1016/S0197-0186(02)00050-5
30. Klug GM, Losic D, Subasinghe SS, Aguilar MI, Martin LL, Small DH (2003) Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur J Biochem 270:4282-4293. doi: 10.1046/j.1432-1033.2003.03815.x
31. LeBlanc AC, Goodyear CG (1999) Role of endoplasmic reticulum, endosomal-lysosomal compartments, and microtubules in amyloid precursor protein metabolism of human neurons. J Neurochem 72:1832-1842. doi: 10.1046/j.1471-4159.1999.0721832.x
32. Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, Munch G (2000) Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem 267:4171-4178. doi: 10.1046/j.1432-1327.2000.01452.x
33. Mandal PK, Pettegrew JW (2004) Alzheimer's disease: Soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies. Neurochem Res 29:2267-2272. doi: 10.1007/ s11064-004-7035-1
34. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 61:1171-1174. doi: 10.1111/j.1471-4159.1993.tb03639.x
35. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670-44676. doi: 10.1074/jbc.M204379200
36. Mazur-Kolecka B, Frackowiak J, LeVine H, Haske T, Evans L, Sukontasup T, Golabek A (2003) TGF-beta1 enhances formation of cellular A beta/ApoE deposits in vascular myocytes. Neurobiol Aging 24:355-364. doi: 10.1016/ S0197-4580(02)00095-7
37. Mazur-Kolecka B, Kowal D, Sukontasup T, Dickson D, Frackowiak J (2004) The effect of oxidative stress on APP production in cells engaged in β-amyloidosis is related to apoE genotype. Acta Neuropathol 108:287-294. doi: 10.1007/s00401-004-0890-7
38. McLaurin J, Yang D, Fraser PE (2000) Review: Modulating factors in amyloid-beta formation. J Struct Biol 130:259-270. doi: 10.1006/ jsbi.2000.4289
39. Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP (2001) Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304:102-106. doi: 10.1016/S0304-3940(01)01754-2
40. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301:41-52. doi: 10.1006/abbi.1993.1112
41. Miller DL, Potempska A, Mehta P (2007) Humoral immune responses to peptides derived from the beta-amyloid peptide C-terminal sequence. Amyloid 14:39-50. doi: 10.1080/13506120601116500
42. Mok SS, Evin G, Li Q-X, Smith AI, Beyreuther K, Masters CL, Small DH (1997) A novel metalloproteinase in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments. Biochemistry 36:156-163. doi: 10.1021/bi961848w
43. Morris CM, Kerwin JM, Edwardson JA (1994) Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 3:267-275
44. Palmblad M, Westlind-Danielsson A, Bergquist J (2002) Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers. J Biol Chem 277:19506-19510. doi: 10.1074/jbc.M112218200
45. Petrat F, de Groot H, Sustmann R, Rauen U (2002) The chelatable iron pool in living cells: A methodically defined quantity. Biol Chem 383:489-502. doi: 10.1515/BC.2002.051
46. Potempska A, Mack K, Mehta P, Kim KS, Miller DL (1999) Quantification of sub-femtomole amount of Alzheimer amyloid β peptides. Amyloid 6:14-21
47. Randell EW, Parkes JG, Olivieri NF, Templeton DM (1994) Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron. J Biol Chem 269:16046-16053
48. Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30:447-450. doi: 10.1016/ S0891-5849(00)00494-9
49. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842. doi: 10.1038/nm1782
50. Siegel SJ, Bieschke J, Powers ET, Kelly JW (2007) The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46:1503-1510. doi: 10.1021/bi061853s
51. Stewart PA, Hayakawa K, Akers MA, Vinters HV (1992) A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67:734-742
52. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612-11622. doi: 10.1074/ jbc.M210207200
53. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK (2004) Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-3599. doi: 10.1523/JNEUROSCI.5167-03.2004
54. Tjernberg LO, Naslund J, Thyberg J, Gandy SE, Ternius L, Nordstedt C (1997) Generation of Alzheimer amyloid β peptide through nonspecific proteolysis. J Biol Chem 272:1870-1875. doi: 10.1074/ jbc.272.19.12601
55. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers. J Physiol 572:477-492. doi: 10.1113/jphysiol.2005.103754
56. Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM (2008) Aβ inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 29:1607-1618. doi: 10.1016/j.neurobiolaging.2007.04.014
57. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, Stanley HE (2004) In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci USA 101:17345-17350. doi: 10.1073/ pnas.0408153101
58. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741. doi: 10.1126/science.286.5440.735
59. Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley T, Ferreiro J, Akers MA (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastruct Pathol 18:333-348. doi: 10.3109/ 01913129409023202
60. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39:10831-10839. doi: 10.1021/ bi001048s
61. Wan S, Hua Y, Keep RF, Hoff JT, Xi G (2006) Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir Suppl (Wien) 96:199-202. doi: 10.1007/3-211-30714-1_43
62. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 18:253-266. doi: 10.1111/j.1750-3639.2008.00133.x
63. Wisniewski HM, Wegiel J (1994) β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 87:233-241. doi: 10.1007/ BF00296738
64. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964-2969. doi: 10.1161/01.STR.0000103140.52838.45
65. Yamaguchi H (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: An immunoelectron microscopic study. Am J Pathol 141:249-259